More stories

  • in

    Higher inflation and unemployment cast shadow over Europe’s biggest economy

    German inflation rose by a higher-than-expected 2.1% in August, preliminary data showed Friday.
    The data came on the same day that figures showed unemployed jumped in August.
    The inflation hike print comes on the same day as an increase in unemployment rates.
    ING’s Carsten Brzeski said the inflation reading weakens the case for the European Central Bank to press ahead with an interest rate cut at its September meeting.

    A vendor gives a customer change at stall at a farmers market in Hanau, Germany, on Saturday, Aug. 9, 2025.
    Alex Kraus | Bloomberg | Getty Images

    Increases in unemployment and inflation cast a shadow over the outlook for Europe’s largest economy, which joins the wider EU bloc in bracing for the full impact of newly implemented U.S. tariffs.
    German inflation rose by a higher-than-expected 2.1% in August, preliminary data showed Friday, exceeding the 2% expectations of analysts polled by Reuters. Inflation, which is harmonized for comparability across the euro zone, had risen by a cooler-than-expected 1.8% in July.

    Germany’s core inflation, which excludes food and energy prices, was unchanged from the previous month at 2.7% in August, the country’s statistics office Destatis said.
    Yields on German government bonds, known as Bunds, were little changed shortly after the data release, which came on the same day that labor office figures showed the number of unemployed people jumped to 3.025 million in August, to a rate of 6.4%.
    The broader euro zone inflation reading, due Tuesday, will offer further insight into the economic impact of U.S. President Donald Trump’s tariff policies, which have hit various European sectors in recent months.
    The U.S. and EU struck a trade agreement in July, including a 15% tariff rate on many EU goods exported to the U.S. Fresh details released earlier this month suggested that this blanket rate will also be applied to some hotly contested sectors like pharmaceuticals — but crucial questions still remain unanswered, leaving businesses on edge.
    The tariffs are widely expected to drive prices higher in the U.S., but their effect on costs elsewhere is less clear.

    Germany’s highly export-driven economy has long been hovering near the flatline. The country’s gross domestic product expanded by 0.3% in the first quarter, before contracting by 0.3% in the following period, according to the latest data from Destatis.
    “It remains to be seen how European and US companies will react to US tariffs. While one scenario could see prices falling in the eurozone due to overcapacity and weaker sales in the US, globally operating companies might try to actually increase prices in Europe in order to offset profit-squeezing in the US,” said Carsten Brzeski, global head of macro at ING, in a note.
    “A rather domestic theme will be the cooling of the German labour market, which should take away wage pressures and consequently inflationary pressures,” he added, noting that the inflationary hike in Germany now weakens the case for the European Central Bank to press ahead with an interest rate cut at its September meeting.
    The ECB most recently opted to hold its key rate unchanged at 2% during its July meeting. More

  • in

    Indian rupee tumbles to new low on Trump tariff concerns

    Client Challenge

    JavaScript is disabled in your browser.
    Please enable JavaScript to proceed.

    A required part of this site couldn’t load. This may be due to a browser
    extension, network issues, or browser settings. Please check your
    connection, disable any ad blockers, or try using a different browser. More

  • in

    Denmark slashes 2025 growth forecast amid Novo Nordisk slowdown

    Denmark slashed its annual growth forecast to 1.4%, citing expectations of weaker pharmaceutical exports along with a revision to past figures.
    Higher U.S. tariffs and a slowdown in the rapid growth of its star pharma company, Novo Nordisk, contributed to the revision, the economy ministry said.
    However, it hiked its 2026 growth forecast to 2.1% from 1.4% on hopes for a pick-up in consumption.

    The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy is seen outside theri building as the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025.
    Mads Claus Rasmussen | Afp | Getty Images

    Denmark on Friday slashed its annual growth forecast to 1.4% from 3%, in large part due to weaker expectations for pharmaceutical giant Novo Nordisk.
    Denmark has recorded strong annual growth in recent years, with its economy expanding 3.7% last year after getting a major boost from pharmaceutical exports.

    Danish pharma giant Novo Nordisk makes blockbuster weight management drugs Ozempic and Wegovy.
    The economy ministry noted that Denmark’s U.S. exports fell significantly in early 2025 after a huge spike in late 2024, due to both inventory build-up and increased competition in the weight loss drug market, which has seen Novo lose market share. Generic medicines are also squeezing its sales opportunities in the U.S., the ministry said.
    Pharmaceuticals are now expected to contribute just 1.3 percentage points to Denmark’s goods exports growth this year, down from 8.1 percentage points in 2024. Total goods export growth is projected to fall to 2.7% in 2025 from 10.5% the previous year.
    Europe’s pharmaceutical sector has been rocked this year by the threat of sky-high U.S. tariffs, though some certainty has now been provided by the EU-U.S. trade deal.
    The Danish economy ministry said U.S. tariffs had weighed on its growth forecast, while a statistical revision showed that real GDP expanded less in 2021-2024 than previously calculated.

    “Growth in the first quarter of 2025 has also been weaker than previously expected. Together with the American tariff increases and downwardly adjusted expectations for the pharmaceutical industry, this has given rise to a significant downward adjustment of the estimate for GDP growth in 2025,” it said in a statement, according to Google Translate.

    It added that despite the Brussels-Washington trade deal, there remained a “significant degree of unpredictability linked to the U.S. administration’s policy,” which was adding to uncertainty around conditions for Danish exporters, potentially weighing on business investments and activity. Households, meanwhile, remain concerned about global events and high food prices, it said.
    The ministry stressed, however, that despite the lower 2025 growth forecast, its economy remains strong overall, with high employment and inflation expected to be below 2% on an annual basis.
    It revised its growth forecast for 2026 higher, to 2.1% from 1.4%, on expectations for higher private and public consumption.

    Novo woes More

  • in

    Stand up to Trump on Big Tech, says EU antitrust chief

    Client Challenge

    JavaScript is disabled in your browser.
    Please enable JavaScript to proceed.

    A required part of this site couldn’t load. This may be due to a browser
    extension, network issues, or browser settings. Please check your
    connection, disable any ad blockers, or try using a different browser. More

  • in

    America’s new ‘patriotic’ capitalism

    Client Challenge

    JavaScript is disabled in your browser.
    Please enable JavaScript to proceed.

    A required part of this site couldn’t load. This may be due to a browser
    extension, network issues, or browser settings. Please check your
    connection, disable any ad blockers, or try using a different browser. More